SCOTTSDALE HRH — History
CCN 033038 | 3-year financial timeline | COVID resilience: 37/100
🛡️ Public data only — no PHI permitted on this instance.
$26M
Latest Revenue (FY2022)
-1.2%
Revenue CAGR (3yr)
3.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $27M | $28M | $26M | -6.5% | -1.2% |
| Operating Expenses | $24M | $24M | $26M | +5.9% | +2.5% |
| Operating Margin | 10.1% | 14.6% | 3.3% | -77.4% | -43.0% |
| Net Income | $3M | $4M | $1M | -78.9% | -43.7% |
| Licensed Beds | 50 | 50 | 50 | +0.0% | +0.0% |
| Total Patient Days | 16,897 | 16,473 | 15,454 | -6.2% | -4.4% |
| Medicare Day % | 41% | 42% | 44% | +4.6% | +3.8% |
| Medicaid Day % | 1% | 0% | 1% | +136.1% | +5.5% |
COVID Impact & Recovery
Resilience Score: 37/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -2.3% ($27M → $26M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-1.2%
This Hospital
+7.6%
State Avg
Latest Margin
3.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $26M | -0.1% |
| FY2024 (proj) | $26M | -3.6% |
| FY2025 (proj) | $26M | -7.0% |